- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate and Severe Plaque Psoriasis
Total 6945 results
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Alza Corporation, DE, USACompleted
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
Galderma R&DCompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
Boston PharmaceuticalsCompletedChronic Plaque PsoriasisGermany
-
Wake Forest UniversityCompleted
-
Eisai Inc.CompletedChronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
Novartis PharmaceuticalsCompletedChronic Plaque Psoriasis
-
Merck KGaA, Darmstadt, GermanyTerminated
-
John MurrayAstellas Pharma US, Inc.TerminatedChronic Plaque Psoriasis
-
Astellas Pharma IncCompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisItaly
-
Rockefeller UniversityDoris Duke Charitable FoundationTerminatedChronic Plaque PsoriasisUnited States
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
Charite University, Berlin, GermanyBiogenCompleted
-
NeoStrata Company, Inc.CompletedChronic Plaque PsoriasisUnited States
-
Uni-PharmaBiogenCompletedChronic Plaque Psoriasis
-
AbbVieCompletedChronic Plaque PsoriasisUnited States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
-
Taro Pharmaceuticals USACompletedPlaque PsoriasisUnited States
-
Taro Pharmaceuticals USACompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.Completed
-
Innovation Pharmaceuticals, Inc.CompletedChronic Stable Plaque PsoriasisUnited States
-
Tasly Pharmaceutical Group Co., LtdNot yet recruiting
-
Eli Lilly and CompanyCompleted
-
PfizerCompleted
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Sun Pharmaceutical Industries LimitedTerminatedPlaque PsoriasisUnited States
-
Sun Pharmaceutical Industries LimitedNovum Pharmaceutical Research ServicesWithdrawn
-
SandozHexal AGCompletedChronic Stable Plaque PsoriasisGermany, Romania, Bulgaria, Czech Republic, Estonia, Hungary, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Japan, France, Israel, Norway, Iceland
-
University of California, San FranciscoCompletedChronic Stable Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States, Estonia, Japan, Latvia, Canada, Iceland
-
Arxx TherapeuticsRecruitingHealthy Volunteers | Mild to Moderate PsoriasisUnited Kingdom
-
Aga Khan UniversityJohn Snow, Inc.; Pakistan Ministry of HealthCompleted
-
Kadmon Corporation, LLCCompletedChronic Plaque PsoriasisUnited States
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
Novartis PharmaceuticalsCompleted
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, France, Estonia, Canada
-
AbbViePPDRecruitingPlaque Psoriasis | Crohn Disease | Psoriatic Arthritis | Other Conditions for Which Risankizumab is an FDA-approved TreatmentUnited States
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Canada
-
International Centre for Diarrhoeal Disease Research...CompletedModerate and Severe UndernutritionBangladesh
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisChina, Thailand, Philippines, Turkey, Hungary, Malaysia